Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. 20816828 2010
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. 19664757 2010
Entrez Id: 351
Gene Symbol: APP
APP
0.400 GeneticVariation phenotype BEFREE An increased amount or mutation(s) in PS1, which alters the stoichiometric balance of the gamma-secretase complex, may be the cause of aberrant or increased processing of APP, resulting in Abeta accumulation leading to loss of memory. 19181896 2009
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease. 19770021 2009
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice. 18599028 2008
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. 18191838 2008
Entrez Id: 351
Gene Symbol: APP
APP
0.400 GeneticVariation phenotype BEFREE The amyloid hypothesis does not adequately address the pathogenesis of the disease, however, since transgenic mice that express the pathologic mutations of the APP and presenilin-1 (PS1) genes produce amyloid plaques but fail to exhibit neurodegeneration and memory loss observed in AD patients. 17981591 2008
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype CTD_human Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. 15364477 2004
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype BEFREE This suggests that the memory loss in APP+PS1 transgenic mice may model the early memory dysfunction in AD before the degeneration of synapses and neurons. 12832546 2003
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker phenotype BEFREE A significant component of memory loss in APP transgenic mice is apparently caused by soluble A Beta assemblies, but whether and how much of the dementia within individuals afflicted with AD is caused by these A Beta species is unclear. 11773429 2002
Entrez Id: 351
Gene Symbol: APP
APP
0.400 GeneticVariation phenotype BEFREE Transgenic mice which carried the mutant form of the beta-amyloid precursor protein gene expressed high concentrations of mutant copy of the gene and exhibited abundant amyloid plaques in the brain and memory loss. 9206974 1997
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE Brain aging and Alzheimer's disease both demonstrate the accumulation of beta-amyloid protein containing "plaques" and tau protein containing "tangles" that contribute to accelerated memory loss and cognitive decline. 30728442 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE This study investigated if resveratrol (RES) can protect against cadmium chloride (CdCl<sub>2</sub>)-induced memory loss and Tau protein hyperphosphorylation in rats and explored its effect on AMPK/PI3K/Akt signaling pathway. 30478674 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE The tau protein aggregates in aging and Alzheimer disease and may lead to memory loss through disruption of medial temporal lobe (MTL)-dependent memory systems. 31653847 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human Importance of tau in cognitive decline as revealed by developmental exposure to lead. 29203278 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 GeneticVariation phenotype BEFREE MAPT p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy. 30546007 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. 29860433 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype BEFREE Alzheimer's disease (AD) is a neurodegenerative disorder characterized by loss of memory and cognitive abilities, and the appearance of amyloid plaques composed of the amyloid-β peptide (Aβ) and neurofibrillary tangles formed of tau protein. 25763997 2016
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. 24556215 2014
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human A proteomic analysis of MCLR-induced neurotoxicity: implications for Alzheimer's disease. 22430071 2012
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 AlteredExpression phenotype BEFREE It is widely known that exogenous formaldehyde exposure induces human cognitive impairment and animal memory loss; and recent studies show that formaldehyde at pathological levels induces Aβ deposition and misfolding of tau protein to form globular amyloid-like aggregates. 19879019 2011
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 AlteredExpression phenotype BEFREE To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. 17409229 2007
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.370 Biomarker phenotype CTD_human Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. 12368474 2002
Entrez Id: 5663
Gene Symbol: PSEN1
PSEN1
0.350 Biomarker phenotype CTD_human Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease. 28448946 2017
Entrez Id: 5663
Gene Symbol: PSEN1
PSEN1
0.350 AlteredExpression phenotype BEFREE Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention. 27388605 2016